Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × 1-dodecylpyridoxal × 1 year × Clear all

Sponsor

Conditions

Ovarian Neoplasms 3 Fallopian Tube Neoplasms 3 Carcinoma, Ovarian Epithelial 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Melanoma 1 Lymphoma, Follicular 1 Lymphoma 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Adenoviridae Infections 1

Interventions

Cyclophosphamide 11 Prednisone 8 Doxorubicin 8 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 7 Vincristine 6 Azacitidine 5 fludarabine 4 Gemcitabine 4 Etoposide 4 Brentuximab Vedotin 4 romidepsin 3 belinostat 3 Dexamethasone 3 Biopsy 3 10-propargyl-10-deazaaminopterin 3 tazemetostat 2 ruxolitinib 2 pembrolizumab 2 Lenalidomide 2 Bendamustine Hydrochloride 2 venetoclax 1 tislelizumab 1 tipifarnib 1 thymoglobulin 1 sodium-iodide symporter 1 selinexor 1 relatlimab 1 pomalidomide 1 ixazomib 1 ivarmacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡